Suppr超能文献

接受激素替代疗法的日本女性乳腺癌发病率未增加:日本乳腺癌风险病例对照研究综述

No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan.

作者信息

Saeki Toshiaki, Sano Muneo, Komoike Yoshifumi, Sonoo Hiroshi, Honjyo Hideo, Ochiai Kazunori, Kobayashi Tadashi, Aogi Kenjiro, Sato Nobuaki, Sawai Seiji, Miyoshi Yasuo, Takeuchi Masahiro, Takashima Shigemitsu

机构信息

Department of Breast Oncology, Saitama Medical University School of Medicine, Saitama, 350-1241, Japan.

出版信息

Int J Clin Oncol. 2008 Feb;13(1):8-11. doi: 10.1007/s10147-007-0728-0. Epub 2008 Feb 29.

Abstract

Hormone replacement therapy (HRT) has been considered one of the main risk factors for breast cancer. Studies demonstrating the relationship between HRT and breast cancer incidence were conducted in Western countries and the target populations were mainly Caucasians. Since the Women's Health Initiatives demonstrated that HRT increased the risk of breast cancer with statistical significance, the number of HRT users in the United States has dramatically decreased. A recent case-control study has investigated the relationship between HRT and breast cancer in Japan, and here we review the results of this study to compare any discrepancy in breast cancer risk between Japanese and Western populations. For this case-control study, at seven institutions, women between the ages of 45 through 69 years, with histologically confirmed breast cancer, were selected as the case group. An age-adjusted control group was selected, using hospital-based data, including records of those screened for lung, gastrointestinal, and gynecological cancer. Questionnaires were administered, and items questioned included various factors related to the incidence of breast cancer: age at diagnosis, body mass index (BMI), smoking habit, age at menopause, birth history, number of births, number of children, history of breast feeding, familial background, and menopausal status. In total, 6183 samples (98.4% of the estimated samples) were put into the database. Data from 276 samples were excluded due to ineligibility. Finally, 5861 samples (3434 cases and 2427 controls) were analyzed. In 3316 cases, 164 (5.0%) patients received hormone-replacement therapy (HRT); on the other hand, 253 (10.7%) of 2355 controls received HRT. The odds ratio was 0.432 (95% confidence intervals [CI], 0.352-0.53), and there was a significantly negative correlation between HRT use and breast cancer. The risk factors in Japanese women showed similar profiles to those in women in Western countries. However, we did find some different profiles of breast cancer risk in the Japanese women. Changing of lifestyle may increase breast cancer risk in Japan.

摘要

激素替代疗法(HRT)一直被认为是乳腺癌的主要风险因素之一。证明HRT与乳腺癌发病率之间关系的研究在西方国家进行,目标人群主要是白种人。自妇女健康倡议表明HRT会显著增加乳腺癌风险以来,美国使用HRT的人数急剧下降。最近一项病例对照研究调查了日本HRT与乳腺癌之间的关系,在此我们回顾该研究结果,以比较日本和西方人群在乳腺癌风险方面的差异。在这项病例对照研究中,在7家机构,选择年龄在45至69岁之间、经组织学确诊为乳腺癌的女性作为病例组。使用基于医院的数据,包括肺癌、胃肠道癌和妇科癌筛查记录,选择年龄调整后的对照组。进行问卷调查,询问的项目包括与乳腺癌发病率相关的各种因素:诊断时的年龄、体重指数(BMI)、吸烟习惯、绝经年龄、生育史、生育次数、子女数量、母乳喂养史、家族背景和绝经状态。总共6183个样本(占估计样本的98.4%)被录入数据库。由于不符合条件,276个样本的数据被排除。最后,对5861个样本(3434例病例和2427例对照)进行了分析。在3316例病例中,164例(5.0%)患者接受了激素替代疗法(HRT);另一方面,2355例对照中有253例(10.7%)接受了HRT。比值比为0.432(95%置信区间[CI],0.352 - 0.53),HRT使用与乳腺癌之间存在显著负相关。日本女性的风险因素与西方国家女性的相似。然而,我们确实发现日本女性在乳腺癌风险方面存在一些不同特征。在日本,生活方式的改变可能会增加乳腺癌风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验